{"id":"https://openalex.org/W3045160920","doi":"https://doi.org/10.1136/annrheumdis-2020-eular.2367","title":"FRI0090 MAINTENANCE OF CLINICAL RESPONSE WITH ABATACEPT IN COMBINATION WITH MTX IN INDIVIDUAL PATIENTS WITH EARLY RA WHO ARE MTX-NA\u00cfVE AND ANTI-CITRULLINATED PROTEIN ANTIBODY (ACPA)+: RESULTS FROM THE INDUCTION PERIOD OF AVERT-2, A RANDOMISED PHASE IIIB STUDY","display_name":"FRI0090 MAINTENANCE OF CLINICAL RESPONSE WITH ABATACEPT IN COMBINATION WITH MTX IN INDIVIDUAL PATIENTS WITH EARLY RA WHO ARE MTX-NA\u00cfVE AND ANTI-CITRULLINATED PROTEIN ANTIBODY (ACPA)+: RESULTS FROM THE INDUCTION PERIOD OF AVERT-2, A RANDOMISED PHASE IIIB STUDY","publication_year":2020,"publication_date":"2020-06-01","ids":{"openalex":"https://openalex.org/W3045160920","doi":"https://doi.org/10.1136/annrheumdis-2020-eular.2367","mag":"3045160920"},"language":"en","primary_location":{"id":"doi:10.1136/annrheumdis-2020-eular.2367","doi":"https://doi.org/10.1136/annrheumdis-2020-eular.2367","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2020-eular.2367","pdf_url":"https://ard.bmj.com/content/annrheumdis/79/Suppl_1/623.2.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ard.bmj.com/content/annrheumdis/79/Suppl_1/623.2.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018678002","display_name":"Paul Emery","orcid":"https://orcid.org/0000-0002-7429-8482","observed_orcids":["https://orcid.org/0000-0002-7429-8482","https://orcid.org/0000-0002-4136-3436"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"P. Emery","raw_affiliation_strings":["LIRMM, University of Leeds, NIHR BRC LTHT, Leeds, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LIRMM, University of Leeds, NIHR BRC LTHT, Leeds, United Kingdom","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015953107","display_name":"Yoshiya Tanaka","orcid":"https://orcid.org/0000-0002-0807-7139","observed_orcids":["https://orcid.org/0000-0002-0807-7139"]},"institutions":[{"id":"https://openalex.org/I188700360","display_name":"University of Occupational and Environmental Health Japan","ror":"https://ror.org/020p3h829","country_code":"JP","type":"education","lineage":["https://openalex.org/I188700360"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Y. Tanaka","raw_affiliation_strings":["University of Occupational and Environmental Health, Kitakyushu, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Occupational and Environmental Health, Kitakyushu, Japan","institution_ids":["https://openalex.org/I188700360"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045325872","display_name":"Vivian P. Bykerk","orcid":"https://orcid.org/0000-0002-1219-3845","observed_orcids":["https://orcid.org/0000-0002-1219-3845"]},"institutions":[{"id":"https://openalex.org/I1281539108","display_name":"Hospital for Special Surgery","ror":"https://ror.org/03zjqec80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1281539108"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"V. Bykerk","raw_affiliation_strings":["Hospital for Special Surgery, New York, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital for Special Surgery, New York, United States of America","institution_ids":["https://openalex.org/I1281539108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108107489","display_name":"Clifton O. Bingham","orcid":"https://orcid.org/0000-0002-4752-5029","observed_orcids":["https://orcid.org/0000-0002-4752-5029"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Bingham","raw_affiliation_strings":["Johns Hopkins University, Baltimore, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University, Baltimore, United States of America","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052842332","display_name":"Tom W. J. Huizinga","orcid":"https://orcid.org/0000-0001-7033-7520","observed_orcids":["https://orcid.org/0000-0001-7033-7520"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"T. Huizinga","raw_affiliation_strings":["Leiden University Medical Center, Leiden, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leiden University Medical Center, Leiden, Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082237505","display_name":"Gustavo Citera","orcid":"https://orcid.org/0000-0002-3724-1874","observed_orcids":["https://orcid.org/0000-0002-3724-1874"]},"institutions":[{"id":"https://openalex.org/I4210111083","display_name":"Instituto Nacional de Rehabilitaci\u00f3n Psicof\u00edsica","ror":"https://ror.org/01z142p52","country_code":"AR","type":"healthcare","lineage":["https://openalex.org/I4210111083"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"G. Citera","raw_affiliation_strings":["Instituto de Rehabilitaci\u00f3n Psicof\u00edsica, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Rehabilitaci\u00f3n Psicof\u00edsica, Buenos Aires, Argentina","institution_ids":["https://openalex.org/I4210111083"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032584805","display_name":"Kuo\u2010How Huang","orcid":"https://orcid.org/0000-0002-0989-0578","observed_orcids":["https://orcid.org/0000-0002-0989-0578"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K.H.G. Huang","raw_affiliation_strings":["Bristol-Myers Squibb, Princeton, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Princeton, United States of America","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057534856","display_name":"Se\u00e1n Connolly","orcid":"https://orcid.org/0000-0003-4884-861X","observed_orcids":["https://orcid.org/0000-0003-4884-861X"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Connolly","raw_affiliation_strings":["Bristol-Myers Squibb, Princeton, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Princeton, United States of America","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063037687","display_name":"Yedid Elbez","orcid":"https://orcid.org/0000-0002-1883-8632","observed_orcids":["https://orcid.org/0000-0002-1883-8632"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y. Elbez","raw_affiliation_strings":["Excelya, Boulogne-Billancourt, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Excelya, Boulogne-Billancourt, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102846742","display_name":"Robert L. Wong","orcid":"https://orcid.org/0000-0003-2949-8132","observed_orcids":["https://orcid.org/0000-0003-2949-8132"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Wong","raw_affiliation_strings":["Bristol-Myers Squibb, Princeton, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Princeton, United States of America","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055062149","display_name":"Karissa L. Lozenski","orcid":"https://orcid.org/0009-0009-4031-4067","observed_orcids":["https://orcid.org/0009-0009-4031-4067"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Lozenski","raw_affiliation_strings":["Bristol-Myers Squibb, Princeton, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Princeton, United States of America","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046261111","display_name":"Roy Fleischmann","orcid":"https://orcid.org/0000-0002-6630-1477","observed_orcids":["https://orcid.org/0000-0002-6630-1477"]},"institutions":[{"id":"https://openalex.org/I162577319","display_name":"The University of Texas at Dallas","ror":"https://ror.org/049emcs32","country_code":"US","type":"education","lineage":["https://openalex.org/I162577319"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Fleischmann","raw_affiliation_strings":["University of Texas, Dallas, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas, Dallas, United States of America","institution_ids":["https://openalex.org/I162577319"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4870,"currency":"USD","value_usd":4870},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"79","issue":null,"first_page":"623","last_page":"623"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13026","display_name":"Natural Compounds in Disease Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abatacept","display_name":"abatacept","score":0.968999981880188},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.9940000176429749},{"id":"https://openalex.org/keywords/early-rheumatoid-arthritis","display_name":"early rheumatoid arthritis","score":0.9649999737739563},{"id":"https://openalex.org/keywords/anti-citrullinated-protein-antibodies","display_name":"anti-citrullinated protein antibodies","score":0.9369999766349792},{"id":"https://openalex.org/keywords/induction-period","display_name":"induction period","score":0.6330000162124634},{"id":"https://openalex.org/keywords/sustained-remission","display_name":"sustained remission","score":0.6129999756813049},{"id":"https://openalex.org/keywords/low-disease-activity","display_name":"low disease activity","score":0.6840000152587891},{"id":"https://openalex.org/keywords/treatment-response-heterogeneity","display_name":"treatment response heterogeneity","score":0.42899999022483826},{"id":"https://openalex.org/keywords/biologic-naive-patients","display_name":"biologic-naive patients","score":0.6919999718666077}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9009069800376892},{"id":"https://openalex.org/C2779605438","wikidata":"https://www.wikidata.org/wiki/Q2697833","display_name":"Abatacept","level":4,"score":0.8106189966201782},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6367412209510803},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6310926675796509},{"id":"https://openalex.org/C2909065710","wikidata":"https://www.wikidata.org/wiki/Q266423","display_name":"Bristol-Myers","level":2,"score":0.5884857177734375},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5767817497253418},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5420755743980408},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5311599969863892},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.4706368148326874},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.44994086027145386},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3675132393836975},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.34731417894363403},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.28958258032798767},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.22576716542243958},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.07401320338249207},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/annrheumdis-2020-eular.2367","doi":"https://doi.org/10.1136/annrheumdis-2020-eular.2367","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2020-eular.2367","pdf_url":"https://ard.bmj.com/content/annrheumdis/79/Suppl_1/623.2.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1136/annrheumdis-2020-eular.2367","doi":"https://doi.org/10.1136/annrheumdis-2020-eular.2367","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2020-eular.2367","pdf_url":"https://ard.bmj.com/content/annrheumdis/79/Suppl_1/623.2.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3045160920.pdf","grobid_xml":"https://content.openalex.org/works/W3045160920.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3040896087","https://openalex.org/W4366769947","https://openalex.org/W2333864817","https://openalex.org/W2327097424","https://openalex.org/W6908833712","https://openalex.org/W3034644808","https://openalex.org/W4323038973","https://openalex.org/W2140082616","https://openalex.org/W2410688849","https://openalex.org/W2519629282"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2020-07-29T00:00:00"}